期刊文献+

树突状细胞与肾细胞癌免疫治疗进展

原文传递
导出
摘要 树突状细胞(DCs)是机体内最有效、功能最强的抗原提呈细胞,其在激发免疫反应中起核心作用,在抗肿瘤免疫中发挥重要作用。近年来采用DCs瘤苗进行肿瘤免疫治疗获得一些突破性进展。本文就DCs与RCC的关系,DCs在RCC免疫治疗中的应用的最新进展作一综述。
出处 《国际泌尿系统杂志》 2006年第3期343-345,共3页 International Journal of Urology and Nephrology
  • 相关文献

参考文献17

  • 1陈彤,郑少斌,谭万龙,李祖国.癌组织树突状细胞浸润与肾癌预后及转移的关系[J].第一军医大学学报,2002,22(9):833-834. 被引量:8
  • 2Troy A,Davidson P,Atkinson C,et al.CD1 a dendritic cell differentiation in cancer.Clinical Cancer Research,2000,6(5):1755-66.
  • 3Menetrier-Caux C,Thomachot MC,Alberti L,et al.IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.Cancer Research,2001,61 (7):3096-104.
  • 4Holtl L,Rieser C,Papesh C,et al.Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells.J Urology,1999,161 (3):777-82.
  • 5Gitlitz B J,Belldegrun AS,Zisman A,Chao DH et al.A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma.J Immunother,2003,26(5):412-9.
  • 6Peter Mulders,et al.Presentation of renal tumor antigens by human dendritic cells actives tumor-infiltrating lymphocytes against autologous tumor:implications for live kidney cancer vaccines.Clinical Cancer Research,1999,2(9):445-54.
  • 7Sievers,Albers P,Schmidt-Wolf IG,Marten A Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma.J Urol,2004,171(1):114-9.
  • 8Avigan D.Dendritic cell-tumor fusion vaccines for renal cell carcinoma.Clin Cancer Res,2004,10(18 Pt 2):6347S-52S.
  • 9Barbuto JA,Ensina LF,Neves AR,et al.Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.Cancer Immunol Immunother,2004,53(12):1111-8.
  • 10Akiyama K,Ebihara S,Yada A,et al.Targeting apoptotic tumor cells to Fc-R provides efficient and versatile vaccination against tumors by dedritic cells.J Immunol,2003,170 (5):1641-48.

二级参考文献4

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部